Search This Blog

Tuesday, January 31, 2023

Cytosorbents higher after the company issued FY22 revenue guidance above analyst estimates

 https://www.benzinga.com/wiim/23/01/30651490/cytosorbents-shares-are-trading-higher-after-the-company-issued-fy22-revenue-guidance-above-analyst

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.